Oxford most prolific university innovator in Europe
Oxford University Innovation launches 24 companies in 2016 with a combined £52.6m in early stage funding, setting a new record in spinout generation for the UK and Europe.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford University Innovation launches 24 companies in 2016 with a combined £52.6m in early stage funding, setting a new record in spinout generation for the UK and Europe.
HTC Vive and virtual reality distance learning platform Engage to showcase the LIFE project from the University of Oxford.
Oxford University forms spinout company to bring fast, cost-effective enzyme development to market.
Oxford University spinouts Genomics and Nanopore partner on utilising handheld nanopore technologies for DNA sequencing.
Oxford University, Oxford University Innovation, Oxford Sciences Innovation and Evotec announce a new partnership to advance the development of next-generation medicines arising from Oxford research.
The fourth annual Oxford Technology Showcase was held on Wednesday 6th July at Oxford’s Saïd Business School. The event brought together experts and innovators from Oxford University, the Oxford University Hospital Trust and the Oxfordshire region. Over 300 investors, entrepreneurs, healthcare companies, researchers and clinicians attended.
In conjunction with Shakespeare’s Dead at the Bodleian’s Weston Library: TalkAbout Guides App available 1 July – 18 September 2016, free download for iOs and Android.
Genomics plc and DNAnexus collaborate to develop solutions for population-scale sequencing analysis
A smartphone game developed by doctors in Kenya and Oxford provides vital emergency care training to African healthcare workers.
Celleron Therapeutics is developing personalised medicine for cancer patients. The company has announced results from its first human trial in patients at Oxford’s Churchill Hospital with advanced treatment-resistant aggressive cancer.